ECTRIMS 2022: Hematopoietic Stem Cell Transplant as Efficacious as Other MS Treatments
Autologous hematopoietic stem cell transplant demonstrated superiority over fingolimod, but had similar efficacy to other DMTs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.